LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM

Reporting ownerCIK 0001701247

Helen Louise Collins

49 transactions in 2 companies, from February 12, 2026 to September 17, 2026.

Transactions: 492 companies
Bought · P: $0open market
Sold · S: $5.4Mopen market
Net: −$5.4Mnet selling

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
Enliven Therapeutics, Inc.	ELVN	48	—	$5.4M
Kura Oncology, Inc.	KURA	1	—	—

All transactions

49 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Sep 17	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Sep 17	SPLAN	240	$51.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Sep 17	SPLAN	1,844	$50.71	$94K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Sep 17	SPLAN	2,916	$50.03	$146K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Sep 17	MPLAN	5,000	$2.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Aug 17	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Aug 17	SPLAN	1,100	$59.35	$65K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Aug 17	SPLAN	3,900	$58.37	$228K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Aug 17	MPLAN	5,000	$2.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Jul 17	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jul 17	SPLAN	63	$53.92	$3K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jul 17	SPLAN	2,184	$53.42	$117K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jul 17	SPLAN	2,063	$52.39	$108K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jul 17	SPLAN	459	$51.55	$24K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jul 17	SPLAN	231	$50.05	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jul 17	MPLAN	5,000	$2.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Jun 17	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jun 17	SPLAN	1,133	$44.74	$51K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jun 17	SPLAN	2,599	$43.87	$114K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jun 17	SPLAN	1,268	$42.83	$54K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Jun 17	MPLAN	5,000	$2.48	$12K
Kura Oncology, Inc.	KURA	Helen Louise CollinsDirDERIV	Jun 4	A	35,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	May 18	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	May 18	SPLAN	223	$41.21	$9K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	May 18	SPLAN	1,302	$40.25	$52K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	May 18	SPLAN	3,475	$39.53	$137K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	May 18	MPLAN	5,000	$2.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Apr 17	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Apr 17	SPLAN	2,441	$48.06	$117K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Apr 17	SPLAN	2,419	$47.39	$115K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Apr 17	SPLAN	140	$45.81	$6K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Apr 17	MPLAN	5,000	$2.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Mar 25	MPLAN	40,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 25	SPLAN	40,000	$35.10	$1.4M
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 25	MPLAN	40,000	$2.48	$99K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Mar 17	MPLAN	5,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 17	SPLAN	5,000	$27.76	$139K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 17	MPLAN	5,000	$2.48	$12K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Mar 10	MPLAN	10,129	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Mar 9	MPLAN	29,871	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 10	SPLAN	10,129	$30.19	$306K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 10	MPLAN	10,129	$2.48	$25K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 9	SPLAN	29,871	$30.02	$897K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Mar 9	MPLAN	29,871	$2.48	$74K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Feb 17	MPLAN	45,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Feb 17	SPLAN	45,000	$26.17	$1.2M
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Feb 17	MPLAN	45,000	$2.48	$112K
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMODERIV	Feb 12	A	150,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Helen Louise CollinsCMO	Feb 12	A	25,000	$0.00	—